A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma. - Zhang Y; Urquijo MA; Zitnay RG; Marks K; Belote RL; Hansen MMK; Ferita M; Neuendorf HM; Liu T; Smith EA; Mehrabad EM; Hejna M; et al. (Cell reports, 2025)